MICHAEL ITTMANN to Middle Aged
This is a "connection" page, showing publications MICHAEL ITTMANN has written about Middle Aged.
Connection Strength
0.271
-
Comparative analysis of p16 expression among African American and European American prostate cancer patients. Prostate. 2019 08; 79(11):1274-1283.
Score: 0.037
-
Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clin Cancer Res. 2010 Jul 15; 16(14):3539-47.
Score: 0.020
-
Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancer. Cell Rep Med. 2025 Aug 19; 6(8):102255.
Score: 0.014
-
Kallikrein gene family as biomarkers for recurrent prostate cancer. Croat Med J. 2020 Oct 31; 61(5):450-456.
Score: 0.010
-
Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases. Histopathology. 2020 Dec; 77(6):890-899.
Score: 0.010
-
CD8 infiltration is associated with disease control and tobacco exposure in intermediate-risk oropharyngeal cancer. Sci Rep. 2020 01 14; 10(1):243.
Score: 0.010
-
Association of Genetic Ancestry With DNA Methylation Changes in Prostate Cancer Disparity. Anticancer Res. 2019 Nov; 39(11):5861-5866.
Score: 0.010
-
JNK1/2 represses Lkb1-deficiency-induced lung squamous cell carcinoma progression. Nat Commun. 2019 05 14; 10(1):2148.
Score: 0.009
-
MicroRNAs as prognostic markers in prostate cancer. Prostate. 2019 02; 79(3):265-271.
Score: 0.009
-
Cellular interactions of the phosphorylated form of AKT in prostate cancer. Hum Pathol. 2017 05; 63:98-109.
Score: 0.008
-
Positive association of collagen type I with non-muscle invasive bladder cancer progression. Oncotarget. 2016 Dec 13; 7(50):82609-82619.
Score: 0.008
-
Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens. BMC Cancer. 2016 11 05; 16(1):853.
Score: 0.008
-
The role of ATP-binding cassette transporter genes in the progression of prostate cancer. Prostate. 2016 Apr; 76(5):434-44.
Score: 0.007
-
The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells. Tumour Biol. 2016 Mar; 37(3):4183-92.
Score: 0.007
-
Role of miR-145 in human laryngeal squamous cell carcinoma. Head Neck. 2016 Feb; 38(2):260-6.
Score: 0.007
-
Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells. PLoS One. 2014; 9(9):e106289.
Score: 0.007
-
Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer. Prostate. 2014 Nov; 74(15):1498-505.
Score: 0.007
-
Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer. Int J Cancer. 2015 Feb 15; 136(4):875-9.
Score: 0.007
-
miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer. PLoS One. 2014; 9(6):e98675.
Score: 0.007
-
HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer. Invest New Drugs. 2014 Apr; 32(2):235-242.
Score: 0.006
-
Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort. Ann Clin Lab Sci. 2013; 43(1):11-21.
Score: 0.006
-
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy. J Mol Diagn. 2013 Mar; 15(2):270-9.
Score: 0.006
-
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy. Clin Cancer Res. 2011 Nov 15; 17(22):7174-82.
Score: 0.005
-
Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk. Prostate. 2011 Sep 15; 71(13):1382-9.
Score: 0.005
-
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens. Am J Pathol. 2011 Jan; 178(1):79-87.
Score: 0.005
-
Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer. J Urol. 2010 Jul; 184(1):149-56.
Score: 0.005
-
Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX. J Clin Virol. 2009 Oct; 46(2):154-60.
Score: 0.005
-
DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy. J Urol. 2009 Apr; 181(4):1678-85.
Score: 0.005
-
Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt. Clin Cancer Res. 2008 Nov 15; 14(22):7511-8.
Score: 0.004
-
Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res. 2007 Jul 01; 13(13):3796-802.
Score: 0.004
-
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis. J Urol. 2007 May; 177(5):1753-8.
Score: 0.004
-
Elevated caveolin-1 levels in African-American versus white-American prostate cancer. Clin Cancer Res. 2000 Sep; 6(9):3430-3.
Score: 0.003
-
Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men. Prostate. 1999 Aug 01; 40(3):172-7.
Score: 0.002
-
Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer. 1998 Feb; 21(2):166-71.
Score: 0.002
-
Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998 Feb; 159(2):471-5; discussion 475-6.
Score: 0.002
-
Oncocytic adenoma of the parotid gland with psammoma bodies. Arch Pathol Lab Med. 1986 Jul; 110(7):640-4.
Score: 0.001